Search

Your search keyword '"Correale C"' showing total 227 results

Search Constraints

Start Over You searched for: Author "Correale C" Remove constraint Author: "Correale C"
227 results on '"Correale C"'

Search Results

1. Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: Data of a national study (ESCAPE-IBD)

2. Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study

3. OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY

4. Signs and symptoms of COVID-19 in patients with multiple sclerosis

8. The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis

9. Signs and symptoms of COVID-19 in patients with multiple sclerosis

10. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

15. Static compliance and driving pressure are associated with ICU mortality in intubated COVID-19 ARDS

17. Outcomes of COVID-19 patients intubated after failure of non-invasive ventilation: a multicenter observational study

25. THE NATURAL CLINICAL COURSE AFTER PER-ORAL ENDOSCOPIC MYOTOMY: IS MICROBIAL TRANSLOCATION THE KEY? A PROSPECTIVE RANDOMIZED CLINICAL TRIAL

28. Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer

29. Do Attachment Styles and Family Functioning Predict Adolescents’ Problematic Internet Use? A Relative Weight Analysis

31. y ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE

32. RAPID DETECTION OF ANTI-INFLIXIMAB ANTIBODIES IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13: PERFORMANCE COMPARISON WITH ELISA

33. RISK OF MICROBIAL TRANSLOCATION IN PER-ORAL ENDOSCOPIC MYOTOMY (POEM) FOR ACHALASIA: ANTIBIOTIC PROPHYLAXIS OR SHORT-THERAPY? AN INTERIM ANALYSIS OF A PROSPECTIVE RANDOMIZED CLINICAL TRAIL

34. P.06.12 RISK OF MICROBIAL TRANSLOCATION IN PATIENTS UNDERGOING PER-ORAL ENDOSCOPIC MYOTOMY FOR ACHALASIA.PRELIMINARY RESULTS

35. Fenomeni carsici tardo-Messiniani

36. The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD)

37. Patients in intensive care unit for COVID-19 pneumonia: the lung ultrasound patterns at admission and discharge. An observational pilot study

38. DOP008 The absence of the Triggering Receptor Expressed on Myeloid Cells type-2 (TREM-2) induces a transmissible and protective intestinal microbiota for colitis and colitis associated cancer

48. 4 - The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6

Catalog

Books, media, physical & digital resources